Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-0485-2009

Dimension Enzymatic Creatinine Flex reagent cartridge, DF270. The ECRE method is an in vitro diagnostic test...

Siemens Healthcare Diagnostics Inc. / initiated 2008-09-29 / Terminated / root cause: design

Dade Behring, Inc. began a recall of Dimension Enzymatic Creatinine Flex reagent cartridge, DF270. The ECRE method is an in vitro diagnostic test for the quantitative measurement of creatinine in... on . The reason FDA records is "Reagent may exhibit unflagged inaccurate patient sample results". As of , the recall status on record is Terminated, and MDM tags the root cause as design.

Recall record

Recall number
Z-0485-2009
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Siemens Healthcare Diagnostics Inc.
Product
Dimension Enzymatic Creatinine Flex reagent cartridge, DF270. The ECRE method is an in vitro diagnostic test for the quantitative measurement of creatinine in human serum, plasma, and urine on the clinical chemistry system. Creatinine measurements are used in the diagnosis and treatment of renal diseases, in monitoring renal dialysis, and as a calculation basis for other urine analytes.
Product code
JFY Enzymatic Method, Creatinine
Reason for recall
Reagent may exhibit unflagged inaccurate patient sample results.
Root cause tag
design
FDA root cause
Component design/selection
Action
The recalling firm telephoned all customers on 9/29/08 to inform them of the problem. Customers were issued a letter dated 9/29/08 (and a response form) with instructions. Customers were instructed to complete the response form and fax (302-631-7242) it to Siemens Healthcare Diagnostics. For questions or additional information, contact the Siemens Technical Solutions Center at 800-441-9250.
Quantity in commerce
12,773 cartons
Distribution
Nationwide Distribution.
Product codes and lots
Lot numbers: CB9107, DB9093, DB9100, EB9077, EC9077, FC9062, GA9043, GD9069, and GD9087.